Literature DB >> 446416

Stereoselective inhibition of aromatase by enantiomers of aminoglutethimide.

P E Graves, H A Salhanick.   

Abstract

The dextrorotatory enantiomer of aminoglutethimide is 38 times more potent than the levoenantiomer in inhibiting aromatization of testosterone by human placental microsomes. The spectral affinity constant for microsomal cytochrome P-450 is 36 times greater for the d-enantiomer. Enzymatic inhibition and affinity are highly correlated for each of the isomers as well as for the racemic mixture. Spectral analysis of the interactions of the inhibitors with the substrate supports the evidence for participation of cytochrome P-450 in aromatization.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 446416     DOI: 10.1210/endo-105-1-52

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  21 in total

Review 1.  Clinical pharmacokinetics of endocrine agents used in advanced breast cancer.

Authors:  P E Lønning; E A Lien; S Lundgren; S Kvinnsland
Journal:  Clin Pharmacokinet       Date:  1992-05       Impact factor: 6.447

2.  Proceedings of the British Pharmacological Society, Clinical Pharmacology Section. Ireland, 6-8 July, 1988. Abstracts.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1988-11       Impact factor: 4.335

3.  Proceedings of the Fiftieth Anniversary Meeting of the British Pharmacological Society, University of Oxford, 16-18 September 1981. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1981-12       Impact factor: 8.739

Review 4.  Could aminoglutethimide replace adrenalectomy?

Authors:  A L Harris
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

Review 5.  Mechanisms of action of aminoglutethimide as endocrine therapy of breast cancer.

Authors:  P E Lønning; S Kvinnsland
Journal:  Drugs       Date:  1988-06       Impact factor: 9.546

Review 6.  Suppression of estrogens with aminoglutethimide and hydrocortisone (medical adrenalectomy) as treatment of advanced breast carcinoma: a review.

Authors:  R J Santen
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

7.  Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trial.

Authors:  I E Smith; A L Harris; M Morgan; H T Ford; J C Gazet; C L Harmer; H White; C A Parsons; A Villardo; G Walsh; J A McKinna
Journal:  Br Med J (Clin Res Ed)       Date:  1981-11-28

Review 8.  First generation aromatase inhibitors--aminoglutethimide and testololactone.

Authors:  G Cocconi
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

9.  Effect of aminoglutethimide on murine fetal hepatic erythroid colony formation.

Authors:  P Leung; A S Gidari
Journal:  Experientia       Date:  1985-04-15

10.  Treatment of advanced breast cancer in postmenopausal women with 4-hydroxyandrostenedione.

Authors:  R C Stein; M Dowsett; A Hedley; J Davenport; J C Gazet; H T Ford; R C Coombes
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.